Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Tirzepatide is a once-weekly, dual-incretin peptide it activates both the GIP and the GLP-1 receptor from a single molecule and in published obesity trials it has produced some of the largest average weight reductions of any incretin agent studied to date
Mechanistic Research Perspective Disruption of FOXO4p53 protein interaction Activation of p53-mediated apoptosis pathways Modeling senescent cell survival and removal mechanisms Analysis of transcription-factor signaling networks Investigation of age-related cellular stress responses Primary Research Applications Cellular Senescence Studies: FOXO4-DRI is widely used in experimental models to investigate how senescent cells accumulate and influence tissue function
Ideal supporting ingredients complement copper peptide function without creating conflicts
Oncogene 21 , 88438851 (2002)
Vitamin B12 in Leber hereditary optic neuropathy mutation carriers
Young adult born neurons enhance hippocampal dependent performance via influences on bilateral networks
US$ 20.03
US$ 21.43
US$ 25.61
US$ 27.23
US$ 24.22
US$ 23.41
